Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates
Revolutionary Immunotherapy: Dostarlimab Poised to Transform Solid Tumor Treatment A groundbreaking phase 2 trial indicates that dostarlimab, an innovative immunotherapy drug, is showing remarkable promise in treating early-stage solid tumors. the study reveals that complete responses to dostarlimab in neoadjuvant settings are enabling many patients to avoid surgery, preserving crucial organs and significantly improving their […]
You can read the full story here: Immunotherapy Avoids Surgery in MMR-Deficient Tumors.